We won! Following strong pushback from Peggy Lillis Foundation, The Leapfrog Group, and many other individuals and organizations, the Centers for Medicare and Medicaid Services (CMS) announced yesterday (August 2, 2018) that it will continue the public reporting of Clostridium difficile and other healthcare-associated infections (HAIs). In May, CMS proposed a rule …
“Living the Story You Want to Tell” by Kristal I recently shared a photo of myself on social media, leading many people to comment on how I different I look. They didn’t know how poorly my health has been but could see that I have lost a lot of weight. …
On Saturday, June 2, the family of Judy Dexter held their fifth annual Toss to Stop C. diff Loss Memorial Picnic and Cornhole Tournament. Despite a late afternoon thunderstorm, the Dexters and their guests raised more than $10,000. As always, the Dexters held a fantastic event that made all their guests …
By Angela Kelly Panel Discusses Treatment Options for Newly Diagnosed C. difficile May 22, 2018 [MD Magazine] Fidaxomicin is a relatively new C. diff drug, approved for the treatment of Clostridium difficile in 2011. It is equally effective as the antibiotic vancomycin; however, it significantly reduces the rate of recurrent …
By Angela Kelly Associate and Advocate at Peggy Lillis Foundation Angela Kelly, creator of the website Gutsy Mother and Clostridium difficile (C. diff) survivor, recently interviewed Dr. Negar Ashouri, a pediatric infectious disease specialist at Children’s Hospital of Orange County (CHOC) in Orange, California, one of the top children’s hospitals in …
